Astellas and PeptiDream Enter into Research Collaboration an

Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Ta

TOKYO & KAWASAKI, Japan--(BUSINESS WIRE)--#proteindegrader--Astellas Pharma Inc. (TOKYO: 4503, President and CEO: Naoki Okamura, “Astellas”) and PeptiDream Inc. (TOKYO: 4587, President and CEO: Patrick C. Reid, “PeptiDream”) today announced a research collaboration and license agreement to discover novel protein deg...

Related Keywords

Japan , Tokyo , Keiichi Masuya , Naoki Okamura , Adam Pearson , Patrickc Reid , Astellas Pharma Inc , Tokyo Stock Exchange Prime Section , Peptidream Inc , Ir Public Affairs , Corporate Communications , Astellas Pharma , Peptide Discovery Platform System , Chief Strategy Officer , Protein Degradation , Primary Focuses , Chief Operating Officer , Focus Area Approach ,

© 2025 Vimarsana